Tag Archive for PRO/AH/EDR> COVID-19 update (59): dementia risk, UK REACT, mutation, mAb therapy, WHO, global
PRO/AH/EDR> COVID-19 update (59): dementia risk, UK REACT, mutation, mAb therapy, WHO, global
COVID-19 -- Worldwide/UnknownWang Q, Davis PB, Gurney ME, Xu R. COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement. 2021 Feb 9. doi: 10.1002/alz.12296. Epub ahead of print. PMID: 33559975; The investigators adjusted for demographics and COVID‐19 risk factors (cardiovascular diseases, type 2 diabetes, obesity, asthma, chronic kidney disease), many of which are also risk factors for dementia. In addition, they adjusted Read more [...]
